ID   PHB2_RAT                Reviewed;         299 AA.
AC   Q5XIH7; P70629; P70630;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   02-OCT-2024, entry version 144.
DE   RecName: Full=Prohibitin-2 {ECO:0000305};
DE   AltName: Full=B-cell receptor-associated protein BAP37;
DE            Short=BAP-37;
GN   Name=Phb2 {ECO:0000312|RGD:620203};
GN   Synonyms=Bcap37 {ECO:0000312|EMBL:AAH83705.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAB18746.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-110 AND 274-299.
RC   STRAIN=Wistar Kyoto {ECO:0000312|EMBL:AAB18746.1};
RC   TISSUE=Aortic smooth muscle {ECO:0000312|EMBL:AAB18746.1};
RX   PubMed=10559001; DOI=10.1161/01.atv.19.11.2600;
RA   Adams L.D., Lemire J.M., Schwartz S.M.;
RT   "A systematic analysis of 40 random genes in cultured vascular smooth
RT   muscle subtypes reveals a heterogeneity of gene expression and identifies
RT   the tight junction gene zonula occludens 2 as a marker of epithelioid 'pup'
RT   smooth muscle cells and a participant in carotid neointimal formation.";
RL   Arterioscler. Thromb. Vasc. Biol. 19:2600-2608(1999).
RN   [3] {ECO:0000312|EMBL:AAH83705.1}
RP   PROTEIN SEQUENCE OF 148-157, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [4] {ECO:0000305}
RP   INTERACTION WITH PHB, AND SUBCELLULAR LOCATION.
RX   PubMed=11302691; DOI=10.1006/excr.2001.5166;
RA   Coates P.J., Nenutil R., McGregor A., Picksley S.M., Crouch D.H.,
RA   Hall P.A., Wright E.G.;
RT   "Mammalian prohibitin proteins respond to mitochondrial stress and decrease
RT   during cellular senescence.";
RL   Exp. Cell Res. 265:262-273(2001).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Protein with pleiotropic attributes mediated in a cell-
CC       compartment- and tissue-specific manner, which include the plasma
CC       membrane-associated cell signaling functions, mitochondrial chaperone,
CC       and transcriptional co-regulator of transcription factors and sex
CC       steroid hormones in the nucleus. {ECO:0000250|UniProtKB:O35129}.
CC   -!- FUNCTION: In the mitochondria, together with PHB, forms large ring
CC       complexes (prohibitin complexes) in the inner mitochondrial membrane
CC       (IMM) and functions as a chaperone protein that stabilizes
CC       mitochondrial respiratory enzymes and maintains mitochondrial integrity
CC       in the IMM, which is required for mitochondrial morphogenesis, neuronal
CC       survival, and normal lifespan. The prohibitin complex, with DNAJC19,
CC       regulates cardiolipin remodeling and the protein turnover of OMA1 in a
CC       cardiolipin-binding manner.Also regulates cytochrome-c oxidase assembly
CC       (COX) and mitochondrial respiration. Binding to sphingoid 1-phosphate
CC       (SPP) modulates its regulator activity. Has a key role of mitophagy
CC       receptor involved in targeting mitochondria for autophagic degradation.
CC       Involved in mitochondrial-mediated antiviral innate immunity, activates
CC       RIG-I-mediated signal transduction and production of IFNB1 and pro-
CC       inflammatory cytokine IL6. {ECO:0000250|UniProtKB:O35129}.
CC   -!- FUNCTION: In the nucleus, serves as transcriptional co-regulator. Acts
CC       as a mediator of transcriptional repression by nuclear hormone
CC       receptors via recruitment of histone deacetylases. Functions as an
CC       estrogen receptor (ER)-selective coregulator that potentiates the
CC       inhibitory activities of antiestrogens and represses the activity of
CC       estrogens. Competes with NCOA1 for modulation of ER transcriptional
CC       activity. {ECO:0000250|UniProtKB:O35129}.
CC   -!- FUNCTION: In the plasma membrane, is involved in IGFBP6-induced cell
CC       migration (By similarity). Cooperates with CD86 to mediate CD86-
CC       signaling in B lymphocytes that regulates the level of IgG1 produced
CC       through the activation of distal signaling intermediates. Upon CD40
CC       engagement, required to activate NF-kappa-B signaling pathway via
CC       phospholipase C and protein kinase C activation (By similarity).
CC       {ECO:0000250|UniProtKB:O35129, ECO:0000250|UniProtKB:Q99623}.
CC   -!- SUBUNIT: The mitochondrial prohibitin complex consists of two subunits
CC       (PHB1 and PHB2), assembled into a membrane-associated ring-shaped
CC       supercomplex of approximately 1 mDa (PubMed:11302691). Interacts with
CC       ESR1, HDAC1 and HDAC5 (By similarity). Interacts with ZNF703. Interacts
CC       with STOML2. Interacts with ARFGEF3 (By similarity). Interacts with
CC       SPHK2. Interacts with COX4I1; the interaction associates PHB2 with COX
CC       (By similarity). Interacts with MAP1LC3B (membrane-bound form LC3-II);
CC       the interaction is direct and upon mitochondrial depolarization and
CC       proteasome-dependent outer membrane rupture. Interacts with IGFBP6 (via
CC       C-terminal domain). Interacts with CLPB (By similarity). Interacts with
CC       CD86 (via cytoplasmic domain); the interactions increases after priming
CC       with CD40. Interacts with AFG3L2. Interacts with DNAJC19 (By
CC       similarity). Interacts with AKT2; this interaction may be important for
CC       myogenic differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:O35129, ECO:0000250|UniProtKB:Q99623,
CC       ECO:0000269|PubMed:11302691}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:11302691}. Cytoplasm {ECO:0000269|PubMed:11302691}.
CC       Nucleus {ECO:0000269|PubMed:11302691}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q99623}.
CC   -!- DOMAIN: LC3-interaction region (LIR) is required for interaction with
CC       MAP1LC3B/LC3-II and for Parkin-mediated mitophagy.
CC       {ECO:0000250|UniProtKB:Q99623}.
CC   -!- PTM: Phosphorylated. Tyrosine phosphorylation is indirectly stimulated
CC       by IGFBP6. {ECO:0000250|UniProtKB:Q99623}.
CC   -!- SIMILARITY: Belongs to the prohibitin family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC083705; AAH83705.1; -; mRNA.
DR   EMBL; U75391; AAB18746.1; -; mRNA.
DR   EMBL; U75392; AAB18747.1; -; mRNA.
DR   RefSeq; NP_001013053.1; NM_001013035.1.
DR   AlphaFoldDB; Q5XIH7; -.
DR   SMR; Q5XIH7; -.
DR   BioGRID; 250411; 9.
DR   IntAct; Q5XIH7; 7.
DR   MINT; Q5XIH7; -.
DR   STRING; 10116.ENSRNOP00000017472; -.
DR   CarbonylDB; Q5XIH7; -.
DR   GlyGen; Q5XIH7; 4 sites, 1 O-linked glycan (4 sites).
DR   iPTMnet; Q5XIH7; -.
DR   PhosphoSitePlus; Q5XIH7; -.
DR   jPOST; Q5XIH7; -.
DR   PaxDb; 10116-ENSRNOP00000017472; -.
DR   Ensembl; ENSRNOT00000091464.2; ENSRNOP00000075668.2; ENSRNOG00000012999.8.
DR   Ensembl; ENSRNOT00055017283; ENSRNOP00055013896; ENSRNOG00055010230.
DR   Ensembl; ENSRNOT00060056212; ENSRNOP00060046418; ENSRNOG00060032455.
DR   Ensembl; ENSRNOT00065049967; ENSRNOP00065041046; ENSRNOG00065028930.
DR   GeneID; 114766; -.
DR   KEGG; rno:114766; -.
DR   UCSC; RGD:620203; rat.
DR   AGR; RGD:620203; -.
DR   CTD; 11331; -.
DR   RGD; 620203; Phb2.
DR   eggNOG; KOG3090; Eukaryota.
DR   GeneTree; ENSGT00950000183070; -.
DR   InParanoid; Q5XIH7; -.
DR   OMA; NEGTHFQ; -.
DR   OrthoDB; 1330394at2759; -.
DR   PhylomeDB; Q5XIH7; -.
DR   TreeFam; TF354230; -.
DR   Reactome; R-RNO-8949664; Processing of SMDT1.
DR   Reactome; R-RNO-9840373; Cellular response to mitochondrial stress.
DR   PRO; PR:Q5XIH7; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000012999; Expressed in heart and 18 other cell types or tissues.
DR   ExpressionAtlas; Q5XIH7; baseline and differential.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098800; C:inner mitochondrial membrane protein complex; ISS:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISO:RGD.
DR   GO; GO:0035632; C:mitochondrial prohibitin complex; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0048786; C:presynaptic active zone; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0033218; F:amide binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0046625; F:sphingolipid binding; ISS:UniProtKB.
DR   GO; GO:1990051; P:activation of protein kinase C activity; ISS:UniProtKB.
DR   GO; GO:0140374; P:antiviral innate immune response; ISO:RGD.
DR   GO; GO:0042113; P:B cell activation; ISS:UniProtKB.
DR   GO; GO:0023035; P:CD40 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0030520; P:estrogen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0060749; P:mammary gland alveolus development; ISO:RGD.
DR   GO; GO:0060744; P:mammary gland branching involved in thelarche; ISO:RGD.
DR   GO; GO:0033598; P:mammary gland epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0007005; P:mitochondrion organization; ISO:RGD.
DR   GO; GO:0000423; P:mitophagy; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0033600; P:negative regulation of mammary gland epithelial cell proliferation; ISO:RGD.
DR   GO; GO:1902808; P:positive regulation of cell cycle G1/S phase transition; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0031536; P:positive regulation of exit from mitosis; ISO:RGD.
DR   GO; GO:0002639; P:positive regulation of immunoglobulin production; ISS:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:RGD.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0060762; P:regulation of branching involved in mammary gland duct morphogenesis; ISO:RGD.
DR   GO; GO:1900208; P:regulation of cardiolipin metabolic process; ISS:UniProtKB.
DR   GO; GO:1904959; P:regulation of cytochrome-c oxidase activity; ISS:UniProtKB.
DR   GO; GO:0039529; P:RIG-I signaling pathway; ISO:RGD.
DR   GO; GO:0007062; P:sister chromatid cohesion; ISO:RGD.
DR   CDD; cd03401; SPFH_prohibitin; 1.
DR   Gene3D; 3.30.479.30; Band 7 domain; 1.
DR   InterPro; IPR001107; Band_7.
DR   InterPro; IPR036013; Band_7/SPFH_dom_sf.
DR   InterPro; IPR000163; Prohibitin.
DR   PANTHER; PTHR23222; PROHIBITIN; 1.
DR   PANTHER; PTHR23222:SF1; PROHIBITIN-2; 1.
DR   Pfam; PF01145; Band_7; 1.
DR   PRINTS; PR00679; PROHIBITIN.
DR   SMART; SM00244; PHB; 1.
DR   SUPFAM; SSF117892; Band 7/SPFH domain; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Coiled coil; Cytoplasm;
KW   Direct protein sequencing; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Nucleus; Phosphoprotein; Receptor;
KW   Reference proteome; Repressor; Transcription; Transcription regulation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q99623"
FT   CHAIN           2..299
FT                   /note="Prohibitin-2"
FT                   /id="PRO_0000213886"
FT   REGION          19..49
FT                   /note="Necessary for transcriptional repression"
FT                   /evidence="ECO:0000250|UniProtKB:Q99623"
FT   REGION          150..174
FT                   /note="Necessary for transcriptional repression"
FT                   /evidence="ECO:0000250|UniProtKB:Q99623"
FT   COILED          190..238
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99623"
FT   MOD_RES         128
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99623"
FT   MOD_RES         147
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35129"
FT   MOD_RES         151
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         200
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35129"
FT   MOD_RES         236
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35129"
FT   MOD_RES         250
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99623"
FT   MOD_RES         262
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O35129"
FT   CONFLICT        87
FT                   /note="P -> T (in Ref. 2; AAB18746)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        108
FT                   /note="V -> F (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        287..288
FT                   /note="FT -> LI (in Ref. 2; AAB18747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        294
FT                   /note="L -> F (in Ref. 2; AAB18747)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   299 AA;  33312 MW;  E7699DDD31FCCB69 CRC64;
     MAQNLKDLAG RLPSGPRGMG TALKLLLGAG AVAYGVRESV FTVEGGHRAI FFNRIGGVQQ
     DTILAEGLHF RIPWFQYPII YDIRARPRKI SSPTGSKDLQ MVNISLRVLS RPNAQELPSM
     YQRLGLDYEE RVLPSIVNEV LKSVVAKFNA SQLITQRAQV SLLIRRELTE RAKDFSLILD
     DVAITELSFS REYTAAVEAK QVAQQEAQRA QFLVEKAKQE QRQKIVQAEG EAEAAKMLGE
     ALSKNPGYIK LRKIRAAQNI SKTIATSQNR IYLTADNLVL NLQDESFTRG SDSLIKGKK
//
